News
Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...
Stonestreet was diagnosed with type 2 diabetes in 2009, but kept it a secret. He told Business Insider why he's speaking out ...
A study from the New England Journal of Medicine found new evidence that GLP-1 drugs used for diabetes and obesity could also ...
Obesity and diabetes are closely linked, but the good news is that both are preventable and manageable with early ...
Type 2 diabetes can increase your risk of pancreatic cancer, but the amount of time since your diagnosis can affect your risk ...
In short, this new study offers good news: tirzepatide not only helps people with type 2 diabetes lose harmful body fat, ...
Type 2 diabetes is increasingly affecting young adults due to poor diets and sedentary lifestyles. Early warning signs like ...
1d
Verywell Health on MSNDiabetes Insipidus vs. Diabetes Mellitus: What’s the Difference?Diabetes insipidus affects the kidneys but does not concern blood sugar control like diabetes mellitus. Learn about the ...
A new study from the Karolinska Institutet in Sweden has found that a common type of diabetes medicine might also help ...
A case can be made that Ozempic, which treats type 2 diabetes along with obesity, may yet deliver similar life-saving results ...
1d
Amazon S3 on MSNImproving Type 2 Diabetes and Obesity Through LifestyleDr. Ronald Goldenberg, MD, FRCPC, FACE, Endocrinologist, discusses Improving Type 2 Diabetes and Obesity Through Lifestyle ...
3d
News-Medical.Net on MSNUQ begins first human trial of immunotherapy for Type 1 diabetesResearchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results